BD (BDX) Receives Vizient Innovative Technology Contract for CentroVena One Insertion System

Becton, Dickinson & Company (NYSE:BDX) is one of the best value stocks to buy right now. On June 23, BD (Becton, Dickinson & Company) announced that its CentroVena One Insertion System was awarded an Innovative Technology contract by Vizient, the nation’s largest provider-driven healthcare performance improvement company. This contract recognizes the system as a breakthrough innovation that simplifies central line placement through an all-in-one design, potentially improving both patient outcomes and clinician safety.

The CentroVena One system integrates essential components (including the guidewire, needle, syringe, and catheter) into a single device. By streamlining the insertion process, it achieves 30% fewer procedural steps and can reduce maximum procedure time by up to 50% compared to standard techniques. These efficiencies also help mitigate risks such as contamination, needlestick injuries, and complications like air or guidewire embolisms.

BD (BDX) Receives Vizient Innovative Technology Contract for CentroVena One Insertion System

Selected by hospital experts on Vizient’s client-led councils, this contract validates the clear clinical need for a more standardized approach to central line insertion. By making this technology more accessible to Vizient’s extensive network of healthcare providers, the agreement aims to drive meaningful improvements in procedural consistency, operational efficiency, and overall quality of care.

Becton, Dickinson & Company (NYSE:BDX) is a global medical technology company headquartered in New Jersey. The company manufactures and sells medical supplies, devices, laboratory equipment, and diagnostic products worldwide.

While we acknowledge the risk and potential of BDX as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than BDX and that has 10,000% upside potential, check out our report about the cheapest AI stock.

READ NEXT: 33 Stocks That Should Double in 3 Years and Cathie Wood 2026 Portfolio: 10 Best Stocks to Buy.

Disclosure: None. Follow Insider Monkey on Google News.

1281292 - 11759070 - 1